Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors

  • Saadia A Aziz1,
  • Joshua A Sznol1,
  • Adebowale Adeniran2,
  • Fabio Parisi2,
  • Yuval Kluger2,
  • Robert L Camp2 and
  • Harriet M Kluger1Email author
BMC Clinical Pathology201313:3

DOI: 10.1186/1472-6890-13-3

Received: 22 October 2012

Accepted: 28 January 2013

Published: 1 February 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
22 Oct 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Dec 2012 Reviewed Reviewer Report - Sumanta Pal
28 Dec 2012 Reviewed Reviewer Report - Daniel Cho
22 Jan 2013 Author responded Author comments - Harriet Kluger
Resubmission - Version 3
22 Jan 2013 Submitted Manuscript version 3
24 Jan 2013 Author responded Author comments - Harriet Kluger
Resubmission - Version 4
24 Jan 2013 Submitted Manuscript version 4
Publishing
28 Jan 2013 Editorially accepted
1 Feb 2013 Article published 10.1186/1472-6890-13-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medicine and Yale Cancer Center
(2)
Department of Pathology, Yale University School of Medicine

Advertisement